Glenmark Life Sciences Ltd Q2 FY2024-2025 Results: Summary

Revenue
₹515.41Cr
Net Profits
₹95.32Cr
Net Profit Margins
18.49%
Highlights
Revenue:

Glenmark Life Sciences Ltd’s revenue fell -14.2% since last year same period to ₹515.41Cr in the Q2 2024-2025. On a quarterly growth basis, Glenmark Life Sciences Ltd has generated -13.25% fall in its revenue since last 3-months.

Net Profits:

Glenmark Life Sciences Ltd’s net profit fell -19.72% since last year same period to ₹95.32Cr in the Q2 2024-2025. On a quarterly growth basis, Glenmark Life Sciences Ltd has generated -14.5% fall in its net profits since last 3-months.

Net Profit Margins:

Glenmark Life Sciences Ltd’s net profit margin fell -6.43% since last year same period to 18.49% in the Q2 2024-2025. On a quarterly growth basis, Glenmark Life Sciences Ltd has generated -1.44% fall in its net profit margins since last 3-months.

FAQs

The revenue for Glenmark Life Sciences Ltd in the Q2 results 2024 was ₹515.41Cr.

The net profit for Glenmark Life Sciences Ltd in the Q2 results 2024 was ₹95.32Cr.

The net profit margin for Glenmark Life Sciences Ltd in the Q2 results 2024 was 18.49%.

The revenue for Glenmark Life Sciences Ltd in the Q2 results 2023 was ₹600.73Cr.

The net profit for Glenmark Life Sciences Ltd in the Q2 results 2023 was ₹118.74Cr.

The net profit margin for Glenmark Life Sciences Ltd in the Q2 results 2023 was 19.77%.